Search results

This is a release of management information for anonymous summary data for those patients that have been identified on the Shielded Patient List (SPL). Its purpose is to make the summary data available to a wider audience, as open data, to enable a broad base of users to perform analysis from it.

This is a release of management information for anonymous summary data for those patients that have been identified on the Shielded Patient List (SPL). Its purpose is to make the summary data available to a wider audience, as open data, to enable a broad base of users to perform analysis from it.

This is a release of management information for anonymous summary data for those patients that have been identified on the Shielded Patient List (SPL). Its purpose is to make the summary data available to a wider audience, as open data, to enable a broad base of users to perform analysis from it.

This is a release of management information for anonymous summary data for those patients that have been identified on the Shielded Patient List (SPL). Its purpose is to make the summary data available to a wider audience, as open data, to enable a broad base of users to perform analysis from it.

The number of Clostridium difficile infections reported to Public Health England (PHE), in patients aged two years or older.

The number of Meticillin-resistant Staphylococcus aureus (MRSA) bloodstream infections reported to Public Health England (PHE).

A measure of the proportion of children diagnosed with any type of cancer in a year who are still alive five years after diagnosis.

A measure of the number of adults diagnosed with any type of cancer in a year who are still alive five years after diagnosis.

A measure of the number of adults diagnosed with any type of cancer in a year who are still alive one year after diagnosis.